Sonnet BioTherapeutics Holdings, Inc. Profile Avatar - Palmy Investing

Sonnet BioTherapeutics Holdings, Inc.

Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human sin…

Biotechnology
US, Princeton [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of SONN's Analysis
CIK: 1106838 CUSIP: 83548R105 ISIN: US83548R3030 LEI: - UEI: -
Secondary Listings
SONN has no secondary listings inside our databases.